Novo Nordisk (
NVO) is showing classic strength — bouncing off the cloud, reclaiming structure, and flashing early signs of momentum rotation. This is how you catch continuation trades without chasing.
📊 Technical Breakdown
Ichimoku: Price reclaimed the top of the cloud and is now building above it. Kijun and Tenkan are aligned. This is the first real bullish structure since the March breakdown.
MACD: Histogram curling upward. We’re not fully bullish yet, but the pressure is shifting back to buyers.
R1 Pivot ($81.31) is the first big test. A clean break above that opens the path toward R2 and beyond.
🎯 Trade Specs
Entry: $71.58
Target: $93.33 (+30.44%)
Stop: $67.00 (–6.42%)
Risk/Reward: 4.74 — elite-level skew for a high-quality name
📊 Technical Breakdown
Ichimoku: Price reclaimed the top of the cloud and is now building above it. Kijun and Tenkan are aligned. This is the first real bullish structure since the March breakdown.
MACD: Histogram curling upward. We’re not fully bullish yet, but the pressure is shifting back to buyers.
R1 Pivot ($81.31) is the first big test. A clean break above that opens the path toward R2 and beyond.
🎯 Trade Specs
Entry: $71.58
Target: $93.33 (+30.44%)
Stop: $67.00 (–6.42%)
Risk/Reward: 4.74 — elite-level skew for a high-quality name
If you found my trades helpful, please consider sending a tip in BTC to: bc1qr35mrh82hykpy9v6znpsyuew85x84ezjyrrf6m
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
If you found my trades helpful, please consider sending a tip in BTC to: bc1qr35mrh82hykpy9v6znpsyuew85x84ezjyrrf6m
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。